Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Chemical Information and Modeling|November 28, 2017
xMaP-An Interpretable Alignment-Free Four-Dimensional Quantitative Structure-Activity Relationship Technique Based on Molecular Surface Properties and Conformer EnsemblesJan Dreher, Josef Scheiber, Nikolaus Stiefl, et al.Journal of Psychiatric Practice|January 15, 2005
Infanticide in female forensic patients: the view from the evolutionary standpointMichael H Stone, Eckhard Steinmeyer, Jan Dreher, et al.Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 20, 2005
[Aggressive behaviour and substance abuse among schizophrenic adolescents compared to antisocial adolescents--a follow-up study]Kathrin Sevecke, Jan Dreher, Petra Walger, et al.European Journal of Medicinal Chemistry|May 8, 2012
2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell linesRenate Determann, Jan Dreher, Knut Baumann, et al.Psychiatry Research|December 2, 2015
Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loadingSvenja Schulze-Rauschenbach, Leonhard Lennertz, Stephan Ruhrmann, et al.European Journal of Medicinal Chemistry|September 21, 2010
QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloidsGerhard Bringmann, Sebastian K Bischof, Steffen Müller, et al.Journal of Medicinal Chemistry|February 23, 2010
Identification of 2-anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generationAnne-Marie Egert-Schmidt, Jan Dreher, Ute Dunkel, et al.Journal of Medicinal Chemistry|December 8, 2022
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A InhibitorDaniel Meibom, Sina Micus, Anna Lena Andreevski, et al.RSC Medicinal Chemistry|June 26, 2023
Target 2035 - an update on private sector contributionsSuzanne Ackloo, Albert A Antolin, Jose Manuel Bartolome, et al.RSC Medicinal Chemistry|February 25, 2022
Target 2035 - update on the quest for a probe for every proteinSusanne Müller, Suzanne Ackloo, Arij Al Chawaf, et al.Pageof 1